XML 53 R30.htm IDEA: XBRL DOCUMENT v3.24.3
Note 10 - Common Stock Incentive, Stock Purchase Plans, and Other Compensation Plans (Tables)
12 Months Ended
Jun. 30, 2024
Notes Tables  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
           

Weighted

 
   

 

   

Average

 
      Shares     Exercise Price  

Outstanding at June 30, 2022

    34,284     $ 40.50  

Granted

    6,962       12.47  

Exercised

           

Canceled or expired

    (3,080 )     139.29  

Outstanding at June 30, 2023

    38,166     $ 27.34  

Granted

    131,840       10.01  

Exercised

           

Canceled or expired

    (13,378 )     10.70  

Outstanding at June 30, 2024

    156,628     $ 14.18  
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]
      

Options

             
      

Outstanding

          

Options

 
      

Weighted-

          

Exercisable

 
      

Average

  

Weighted-

      

Weighted-

 
  

Number

  

Remaining

  

Average

  

Number

  

Average

 
  Outstanding  Contractual  Exercise  Exercisable  Exercise 

Range of exercise prices

    Life (years)  Price     Price 

$7.47 – $19.20

  154,003   8.25  $11.83   21,379  $18.55 

$55.50 – $84.90

  418   4.37   61.52   418   61.52 

$159.00 – $175.50

  2,207   2.86   168.97   2,207   168.97 

$7.47 – $175.50

  156,628   8.17  $14.18   24,004  $33.13 
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
           

Weighted

 
           

Average

 
   

Shares

   

Grant-Date

 
           

Fair Value

 

Outstanding at June 30, 2022

    75,873     $ 39.00  

Granted

    2,150       11.83  

Vested

    (26,742 )     46.68  

Canceled or expired

    (610 )     60.60  

Outstanding at June 30, 2023

    50,671     $ 33.43  

Granted

    20,000       10.10  

Vested

    (26,898 )     45.50  

Canceled or expired

           

Outstanding at June 30, 2024

    43,773     $ 15.36  
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   

Year Ended

   

Year Ended

 

(in thousands)

 

June 30, 2024

   

June 30, 2023

 

Selling, Administration and General

  $ 1,364     $ 1,457  

Research & Development

    114       41  

Total

   $ 1,478      $ 1,498  
Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]
   

Year Ended

   

Year Ended

 
   

June 30, 2024

   

June 30, 2023

 

Expected Dividend Yield

           

Expected Volatility

    99.85 %     104.67 %

Risk-Free Interest Rates

    4.36 %     1.59 %

Expected Option Life (in years)

    3.5       3.5  

Weighted-average grant-date fair value of options awarded

  $ 11.63     $ 20.22